Brief: Jazz Pharmaceuticals Q1 Adjusted EPS USD 6.34 Vs. IBES Estimate USD 4.57
05/05/2026 21:05
May 05 (Reuters) - Jazz Pharmaceuticals Q1 revenue USD 1,068.9 million vs. IBES estimate USD 976.6 million. Q1 net income USD 293.1 million Q1 adjusted net income USD 419.5 million vs. IBES estimate USD 289.7 million Q1 EPS USD 4.43
Recent news on Jazz Pharmaceuticals
See all newsBrief: Jazz Pharmaceuticals Enters Amendment No. 4 To Credit Agreement On Sept 23, 2026
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
Jazz Pharma dips after upsized $1.1 bln convertible offering
Brief: Jazz Pharmaceuticals Announces Private Offering Of $1.0 Billion Of Exchangeable Senior Notes Due 2032